Empagliflozin restores cardiac metabolic flexibility in diet-induced obese C57BL6/J mice
Bingxian Xie, Wesley Ramirez, Amanda M. Mills, Brydie R. Huckestein, Moira Anderson, Martha M. Pangburn, Eric Y. Lang, Steven J. Mullett, Byron W. Chuan, Lanping Guo, IAN J. SIPULA, Christopher Paul O'Donnell, Stacy Gelhaus Wendell, Iain Scott, Michael J. Jurczak
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.1016/j.crphys.2022.05.003 ↗
- Volume · Issue · Pages
- 5 · — · 232-239
- Publisher
- Elsevier BV
- Article URL
- https://doi.org/10.1016/j.crphys.2022.05.003 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Jan 2022
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Jan 2022 | OpenAlex |
Keywords (as given): empagliflozin; SGLT2 inhibitors; diet-induced obesity; insulin resistance; cardiac hypertrophy; myocardial ischemia; heart failure; diabetic cardiomyopathy; cardioprotection
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
Best available information, not a definitive status: Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
- Journal
- Current Research in Physiology
- Publication date used
- 01 Jan 2022 (OpenAlex publication date)
- Applicable HEC period
- hjrs 2021-22 V2 (version 1) · 01 Jul 2021 – 30 Jun 2022
- Category
- —
- Recognition status
- Pending Verification (PERIOD_HAS_UNMATCHED_ROWS)
- Source
- —
- Verification status
- Unverified
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.
